The role of the newly discovered estrogen receptor GPR30 in islet physiology and pathophysiology is 1 unclear. We examined GPR30 expression in relation to hormone secretion and possible anti-apoptotic 2 effects in isolated mouse islets using the synthetic GPR30 ligand G-1. The mRNA and protein Genomic effects of estrogens through the nuclear estrogen receptors (ER) ERα and ERβ have been 10 recognized for a long time in several tissues including the islets of Langerhans (Prossnitz et al.,2007) .
11
Recently, however, several reports have described rapid effects by 17β-estradiol elicited through a 12 non-classical membrane receptor, which has been shown to share the characteristics of a G protein- (Pfaffl,2001 
coupled receptor (GPCR

29
Control experiments showed no differences between female and male mice islets with regard to 30 mRNA expression for ERα and ERβ ( Figure 1A ). Notably ERα expression was almost 10-fold higher 31 than ERβ (p<0.01) in both female and male mice islets ( Figure 1A) . However, the expression of 32 GPR30 mRNA relative to house keeping gene GAPDH was found to be higher in female [(9.5 ± 1.0) x on glucagon release, however, was not further modulated by G-1 ( Figure 3D ). Somatostatin release at 30 basal glucose (1 mM) was not notably affected by 17β-estradiol or G-1 whereas somatostatin secretion 31 at 12 mM glucose was dose-dependently inhibited by both 17β-estradiol and G-1 (Figure 3D and E). 
28
The present study was focused on the expression and function of GPR30 in endocrine pancreas. 
34
There has been extensive work done in other tissues which showed that 17β-estradiol increases 
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